128 related articles for article (PubMed ID: 23106771)
1. Weight of the resected specimen after transurethral resection as a new predictive variable for recurrence of non-muscle-invasive bladder tumour.
De La Peña E; Hernández V; Blázquez C; Martin MD; Díaz FJ; Capitán C; Alemany I; Llorente C
BJU Int; 2013 Apr; 111(4 Pt B):E196-201. PubMed ID: 23106771
[TBL] [Abstract][Full Text] [Related]
2. Weight of the resected specimen after transurethral resection as a new predictive variable for recurrence of non-muscle-invasive bladder tumour.
Goel A; Prakash J; Sharma P
BJU Int; 2013 Apr; 111(4):E138. PubMed ID: 23551448
[No Abstract] [Full Text] [Related]
3. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
[TBL] [Abstract][Full Text] [Related]
4. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
[TBL] [Abstract][Full Text] [Related]
5. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin.
Günlüsoy B; Değirmenci T; Arslan M; Nergiz N; Minareci S; Ayder AR
Urol Int; 2005; 75(2):107-13. PubMed ID: 16123562
[TBL] [Abstract][Full Text] [Related]
6. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
[TBL] [Abstract][Full Text] [Related]
7. Follow-up after surgical treatment of bladder cancer: a critical analysis of the literature.
Soukup V; Babjuk M; Bellmunt J; Dalbagni G; Giannarini G; Hakenberg OW; Herr H; Lechevallier E; Ribal MJ
Eur Urol; 2012 Aug; 62(2):290-302. PubMed ID: 22609313
[TBL] [Abstract][Full Text] [Related]
8. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience.
Mariappan P; Zachou A; Grigor KM;
Eur Urol; 2010 May; 57(5):843-9. PubMed ID: 19524354
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases.
Engeler DS; Wyler S; Neyer M; Hobi C; Müller J; Schmid HP
Scand J Urol Nephrol; 2008; 42(6):522-7. PubMed ID: 18609290
[TBL] [Abstract][Full Text] [Related]
10. [T1 high-grade bladder cancer - value of second operation with prognostuic parameters of first operation: analysis of 167 cases].
Lazica DA; Böttcher S; Degener S; von Rundstedt FC; Brandt AS; Roth S; Störkel S; Mathers MJ
Aktuelle Urol; 2013 Mar; 44(2):124-8. PubMed ID: 23580383
[TBL] [Abstract][Full Text] [Related]
11. Tumor recurrence in prostatic urethra following simultaneous resection of bladder tumor and prostate: a comparative retrospective study.
Jaidane M; Bouicha T; Slama A; Hmida W; Hidoussi A; Ben Sorba N; Mosbah F
Urology; 2010 Jun; 75(6):1392-5. PubMed ID: 19781747
[TBL] [Abstract][Full Text] [Related]
12. Outcome of very large superficial bladder tumours: a 10-year experience.
Gupta SK; Parr NJ
Scand J Urol Nephrol; 2008; 42(3):243-8. PubMed ID: 18432531
[TBL] [Abstract][Full Text] [Related]
13. Should follow-up cystoscopy in bacillus Calmette-Guérin-treated patients continue after five tumour-free years?
Holmäng S; Ströck V
Eur Urol; 2012 Mar; 61(3):503-7. PubMed ID: 22119022
[TBL] [Abstract][Full Text] [Related]
14. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
May M; Helke C; Nitzke T; Vogler H; Hoschke B
Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T
BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
[TBL] [Abstract][Full Text] [Related]
16. The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer.
Richterstetter M; Wullich B; Amann K; Haeberle L; Engehausen DG; Goebell PJ; Krause FS
BJU Int; 2012 Jul; 110(2 Pt 2):E76-9. PubMed ID: 22313727
[TBL] [Abstract][Full Text] [Related]
17. Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy.
Wiesner C; Pfitzenmaier J; Faldum A; Gillitzer R; Melchior SW; Thüroff JW
BJU Int; 2005 Feb; 95(3):301-5. PubMed ID: 15679782
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
Jancke G; Damm O; Rosell J; Jahnson S
Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
[TBL] [Abstract][Full Text] [Related]
19. The role of surveillance in the treatment of patients with muscle-invasive bladder cancer after chemotherapy.
Hellenthal NJ; Ramirez ML; Evans CP; Devere White RW
BJU Int; 2010 Feb; 105(4):485-8. PubMed ID: 19849694
[TBL] [Abstract][Full Text] [Related]
20. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
Zhang M; Tao R; Zhang C; Shen Z
Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]